Frequently Asked Questions. The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore
|
|
- Myles Hood
- 5 years ago
- Views:
Transcription
1 1. Where is the location of the CIRB? The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore When is the submission deadline? The CIRB meets once a month. The submission deadline for the month s Full Board Review (for new studies, amendments, renewals and re-tabled cases) is the first working day of that same month. For new applications, the Principal Investigator should submit with sufficient lead time for the Research Development Office check (if applicable), Department Representative and Institutional Representative to endorse prior to the first working day of the month. Submissions received by CIRB after the first working day may be tabled for the subsequent full board meeting. For studies reviewed under the expedited and exempted procedures, study applications or amendments (that involve minimal or less than minimal risks) may be submitted at any time. 3. How long is the ethics review process? Principal Investigators are advised to submit a complete application on time or in advance before the submission deadline (the first working day of the month). With the exception of the month of December, the time frame from submission to CIRB decision should, under normal circumstance, be within 30 calendar days of that monthly review cycle (which starts on the first working day of the month). However, this could vary depending on several factors such as the completeness, and quality of the application, complexity of the study and response time of the Investigator to CIRB's queries. 4. Do I need to pay for my CIRB application? For studies which are initiated by industry or commercial entities, the following review fees will apply: - Initial IRB Application review involving Single Cluster institution(s) - S$1500,+ prevailing GST rate (i.e. S$1605) Initial Application review involving Cross Cluster institution(s) - S$2,500 + prevailing GST rate (i.e. S$2675) Subsequent Amendments - S$200 + prevailing GST rate (i.e. S$214) Subsequent addition of 1st Cross-cluster site: S$1,000 + prevailing GST rate (i.e. S$1,070) Page 1 of 7
2 5. What training qualification(s) should the Principal Investigator, Co- Investigator or Other Study Team Members submit? The minimum training requirement for SingHealth Study Team Members (e.g. Principal Investigators and Co-Investigators) is completing the Collaborative Institutional Training Initiative (CITI) Certificate for Biomedical Research Investigators and Key Personnel programme. You could access the CITI programme from this link: Please click here for the list of the core modules for the CITI certificate. The minimum training for Principal Investigators conducting clinical trials within SingHealth includes completing the Good Clinical Practice programme (GCP) workshop (in addition to the current requirement for CITI) when making a submission to the CIRB. For clinical trials that require a Clinical Trial Certificate/ Clinical Trial Authorisation/ Clinical Trial Notification from HSA, CIRB will not grant ethics approval for clinical trials applications until a receipt of proof for the Principal Investigator completion of the GCP course is provided. To attend the GCP workshop, you can register with any local institution which offers it, such as SingHealth Academy, National Healthcare Group (Classroombased or Online) and the online igcp course with National University of Singapore. 6. When is the study considered closed? The study is considered closed or completed if there is no more research activities, including contact with participant or any data analysis of identifiable data after which the investigator has to provide the study status report for closure to CIRB. For multi-centre studies, the study may be said to be completed at the sites when no further data will be collected from the sites, regardless of whether the global study has been completed or not 7. What should I submit for Protocol amendment and other documents e.g. Participant Information Sheet and Consent Form? Hardcopy Submission: The Principal Investigator must submit a cover letter with "track changed" version, a clean version of the revised document and include a summary of changes. Please submit one set of documents to 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore Page 2 of 7
3 ishare Approved studies: Please submit an amendment on ishare and make the necessary changes on the CIRB Amendment Form. All proposed changes to the research and the rationale for the change must be listed on the Study Amendment Cover Note. Please remove the previous version and replace with the clean and track changed version of the revised document, together with a summary of change. 8. How do I make changes to the study team members? Hardcopy Submission: The PI should submit the Changes to Study Team Members Form to CIRB for review. Changes should be made on a per study basis (i.e 1 Form for 1 study). For inclusion or changes to PI or site PI, please submit together with the duly signed PI s declaration, Department Representative s Endorsement and Institution Representative s Endorsement Page. For addition of PI or site PI, please submit CV and CITI (Biomedical Research Investigators and Key Personnel Module). For clinical trials, the PI s GCP certificate is also required. For addition of Co-Is and Study Team Members, please submit their CV and CITI (Biomedical Research Investigators and Key Personnel Module). ishare Approved studies: Please submit an amendment and make changes under section B2 of the CIRB application form. 9. Who should be listed as study team members? With effect from 12 Feb 2015, the following study personnel should be listed as study team members* and submitted for CIRB review and approval. The study team members should only carry out research-related activities upon obtaining approval from CIRB. This applies to studies approved through hardcopy submission and ishare submission. Co-investigators - Members of the research/ clinical trial team designated by the Principal Investigator to perform study-related procedure and/or make important research-related decisions. Study Team Members - Personnel responsible for the design, conduct or reporting of the research. Page 3 of 7
4 All personnel who have a responsibility for the consent process and/or direct data collection for the study must be listed as study team members (e.g. Coinvestigators and Study Team Members). If an individual s role on the study is part of his/ her regular duties (i.e. radiographer, imaging technologist) and involvement in the study is limited to performing those duties without contributing to the study goal, such individuals need not be listed as Co-investigators or Study Team Member. *The PI and/or site PI should determine if the study personnel meets the definition of study team members (Co-investigators and Study Team Members). 10. Is there a change in the renewal policy? I noticed that the valid till date is now exactly one year from the approval letter date. It no longer follows the initial valid till date. With the mutual recognition between CIRB and DSRB, we have changed and realigned some of our policies. As of Nov 2014, the renewal policy has been revised to: For study approved by the Full Board Review, the study is approved for a period of one year from the date that the study is reviewed and approved at the meeting. For study reviewed by the Expedited procedure, the approval is for a period of one year from the date the proposal is reviewed by the Chairperson or designee. 11. When should the site start submitting non-local* serious adverse events (SAEs)? The Principal Investigator should start submitting non-local SAEs from the point the study is submitted to CIRB. The safety information should cover the period of time from the last Investigator s Brochure update. It can be submitted as individual CIOMS format or in a summarized version (e.g. line listings or periodic reports). 12. When should the site cease to submit non-local* SAEs? The Principal Investigator may cease to submission of non-local SAEs after the CIRB has been informed of study closure. Page 4 of 7
5 13. What are the CIRB requirements for non-local* SAE reporting of investigational drugs used in clinical trials? For locally-registered drugs, expedited safety reports (i.e. serious, unexpected and related) arising from on-going trials in Singapore site(s) should be reported to CIRB. For locally-unregistered products, expedited safety reports (i.e. serious, unexpected and related) arising from all studies conducted worldwide using the same primary compound should be reported to CIRB. * Non-local SAEs include SAEs from sites not reviewed by CIRB. 14. Do I need to submit advertising/ recruitment materials for CIRB review and approval? When direct advertising (includes, but not limited to newspaper, websites, bulletin boards, posters, flyers, brochures, messages, invitation letters to potential participants, etc.) is to be used, CIRB will review the information contained in the advertisement and the mode of its communication. All advertisements cannot be displayed or used until CIRB has reviewed and approved the final version. CIRB review and approval is not required in the following cases: - Letters to doctors for referring potential participants - Stories in newspapers or magazines that mention the research project - Listing of clinical trials on research website when the format is limited to basic trial information such as protocol title, purpose of study, protocol summary, basic eligibility criteria, study site location and how to contact site for further information 15. Does case report require CIRB review? Studies involving three or more patients (case series) will require CIRB review. Case report of one to two patients does not meet the definition of research as it does not involve systematic analysis/ investigation. Hence, CIRB review is not required. Page 5 of 7
6 The SingHealth Participant information Sheet and Informed Consent Form Template should not be use as the Informed Consent Document for case report studies. 16. How to determine if a Witness or an Impartial Witness is required during the Informed Consent Process? The following table summarizes when a witness or an impartial witness is required during an informed consent process: Clinical Trials regulated by HSA Human Biomedical Research under HBRA Requirement for Witness during informed consent discussion Participant or Participant or Participant s Legal Participant s Legal Representative is Representative is unable to read and/or able to read and/or sign on consent form sign on consent form Impartial Witness* Impartial Witness* Not Required Witness** *Impartial witness - A person who is 21 years of age or older, has mental capacity, who is independent of the research study, and cannot be unfairly influenced by people involved with the research study **Witness - A person who is 21 years of age or older, has mental capacity, who may be/ may not be a member of the team carrying out the research Page 6 of 7
7 Minimum Training Requirements for Staff from SingHealth and Partner Institutions Study Roles PIs and Site PIs conducting clinical trials PIs and Site PIs conducting non- clinical trials Everyone else in Study Team (Co-Investigators and Study Team Members) Training GCP and CITI (Biomedical Research Module - Refer to list below) CITI (Biomedical Research Module - Refer to list below) CITI (Biomedical Research Module) Modules include: 1. Belmont Report and CITI Course Introduction 2. History and Ethics of Human Research 3. Informed Consent 4. Social and Behavioral Research (SBR) for Biomedical Researchers 5. Records-Based Research 6. Genetic Research in Human Populations 7. Populations in Research Requiring Additional Considerations and/or Protections 8. Vulnerable Subjects - Research Involving Prisoners 9. Vulnerable Subjects - Research Involving Children 10. Vulnerable Subjects - Research Involving Pregnant Women, Human Fetuses, and Neonates 11. Conflicts of Interest in Research Involving Human Subjects Page 7 of 7
Mutual Recognition of Research Ethics Review between SingHealth CIRB and NHG DSRB
Mutual Recognition of Research Ethics Review between SingHealth CIRB and NHG DSRB Frequently Asked Questions General 1. What types of cross-cluster studies are eligible for single IRB reviews? All new
More informationCo-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB
Co-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB Frequently Asked Questions 1. What type of collaborative studies is eligible for single IRB reviews? All new collaborative
More informationSetting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016
Setting up a CITI account for users not enrolled at or employed by Georgia Tech Georgia Institute of Technology December 2016 www.citiprogam.org Select REGISTER to establish an account. Affiliate with
More information12.0 Investigator Responsibilities
12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement, the investigational
More informationEthics Committee Composition Roles & Responsibilities. Dr Girish Dayma Dr Sanjay Juvekar KEM Hospital Research Centre Pune
Ethics Committee Composition Roles & Responsibilities Dr Girish Dayma Dr Sanjay Juvekar KEM Hospital Research Centre Pune Outline Introduction Composition Roles & Responsibilities Overview of amendment
More informationDemystifying the IRB
Demystifying the IRB Mariette Marsh, MPA, CIP Assistant Director Human Subjects Protection Program Ms. Marsh is the Assistant Director for Education and Outreach at the Human Subjects Protection Program.
More informationHuman Research Protection Program Institutional Review Board
Human Research Protection Program Institutional Review Board Policies and Procedures Guidebook TABLE OF CONTENTS Federal, State and University Regulations Related to the IRB... Section 1.0 Definition of
More informationThe Greenville Hospital System Office of Research Compliance and Administration HRPP Policies and Procedures
The Greenville Hospital System Office of Research Compliance and Administration HRPP Policies and Procedures Title: Western Institutional Review Board (WIRB) HRPP Policy No. 33.02 Effective Date: May 2012
More informationHuman Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance
Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Continuing review (annual renewal) is no longer required for minimal risk research 2.
More informationINSPIRing Changes to the IRB Process: New templates and more
INSPIRing Changes to the IRB Process: New templates and more John F. Ennever, MD, PhD, CIP Director, Human Research Protection Program Office of Human Research Affairs Boston Medical Center and Boston
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM
ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM Outline Introduction Composition Responsibilities of IEC Responsibilities
More informationFAQs March 12, 2012 FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS Table of Contents (Click to follow links) The National Cancer Institute s Central IRB (NCI CIRB)... 2 Standalone HIPAA Authorizations... 3 Retroactive CRADO Waivers... 4 Implementation
More information4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.
SOP #: MON-101 Page: 1 of 6 1. POLICY STATEMENT: The DF/HCC understands that external sponsors are required to monitor the progress of clinical investigations and ensure appropriate research data collection
More informationLocal VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB
ADMINISTRATIVE INFORMATION Principal Investigator: Study Coordinator: Protocol Title: Current Audit Date: Research Compliance Officer (RCO) or Designated Auditor(s): Local VA VA ORD CSP Other VA ORD Sponsor
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationUtilizing the NCI CIRB
Policy P15 Written By: B. Laurel Elder, Ph.D. Created: September 2, 2011 Edited Version P15.1 Utilizing the NCI CIRB PURPOSE - The purpose of this Standard Operating Procedure (SOP) is to outline the procedures
More information1.2.1 It is the policy of the University of Alabama that qualifying research may be reviewed using an expedited procedure.
POLICY # RESEARCH POLICY & PROCEDURE EXPEDITED REVIEW Approval Date: 2-9-2012 CTM Review Cycle: 1 2 3 Revision Dates: AAHRPP DOC # 66 Responsible Office: Research Compliance 1.0 POLICY 1.1 Background 1.1.1
More informationDr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationPHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR REVIEW/EVALUATION CLINICAL TRIAL APPLICATIONS FOR VACCINES AND BIOLOGICALS MALAWI
PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR REVIEW/EVALUATION OF CLINICAL TRIAL APPLICATIONS FOR VACCINES AND BIOLOGICALS IN MALAWI 1. INTRODUCTION The clinical trial application must undergo a
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationInstitutional Review Board Standard Operating Procedures. Education and Training on Human Subject Research Date Last Revised: OVERVIEW
Page 1 of 6 Document Number: IRB-P106 Version Number: 1.3 Institutional Official: David Carlisle, MD, PhD Title: Institutional Review Board Standard Operating Procedures Education and Training on Human
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationI. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.
Human Research Protection Program Policies & Procedures Unanticipated Problems and Adverse Events Version 3.0 Date Effective: 11.9.2012 Research Integrity Office Mail code L106-RI Portland, Oregon 97239-3098
More informationUniversity of South Carolina. Unanticipated Problems and Adverse Events Guidelines
University of South Carolina Unanticipated Problems and Adverse Events Guidelines These guidelines define the procedures of USC for addressing unanticipated problems involving risks to research participants
More informationLoyola University Chicago Health Sciences Division Maywood, IL. Human Subject Research Project Start-Up Guide
Loyola University Chicago Health Sciences Division Maywood, IL Human Subject Research Project Start-Up Guide This Start-Up Guide is intended to guide you through the process of designing a research project
More informationDrugs and Cosmetics rules, 2013 India
Drugs and Cosmetics rules, 2013 India Dr.Pankaj Shah Professor, Dept of Community Medicine, SRMC & RI, & Member Secretary, IEC II, SRU, Chennai Three important amendments 30 th Jan 2013 1 St Feb 2013 8
More informationGuide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application
Guide to Completing Medical University of South Carolina s Institutional Review Board (IRB) Continuing Review Application This guide has been developed to help researchers complete IRB continuing review
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationINDIANA STATE UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS
INDIANA STATE UNIVERSITY POLICIES AND PROCEDURES FOR THE REVIEW OF RESEARCH INVOLVING HUMAN SUBJECTS This manual is believed to be in full compliance with all applicable Federal and state laws and regulations.
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More information*Applicable to: Beaumont Health. Document Type: Policy
Owner: *For This Document, Includes: Beaumont Corporate Shared Services Beaumont Hospital, Dearborn Beaumont Hospital, Farmington Hills Beaumont Hospital, Grosse Pointe Beaumont Hospital, Royal Oak Beaumont
More informationSummary of the Common Rule Changes
Summary of the Common Rule Changes Category Topic & Details UNC Charlotte Impact Scope Research definition revised (46.102) What is not research and thus does not require IRB review: Most scholarly and
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationNational Cancer Institute. Central Institutional Review Board. Standard Operating Procedures
National Cancer Institute Central Institutional Review Board Standard Operating Procedures CIRB Standard Operating Procedures Additional copies are available from the CIRB website (http://www.ncicirb.org)
More informationIRB 101. Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix
IRB 101 Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix Contents Brief discussion of regulations IRB Structure Levels of Approval Informed Consent HIPAA/HITECH
More informationRESEARCH SUPPORTED BY A DEPARTMENT OF DEFENSE (DOD) COMPONENT
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program RESEARCH SUPPORTED BY A DEPARTMENT OF DEFENSE (DOD) COMPONENT 2/19/2016 The following special considerations apply to research involving
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationAsk the Experts Panel
Ask the Experts Panel Compliance in Research Colleen Fritsche, Assistant Director of Office of Animal Care and Use Cassie Myers, Deputy Director of Office of Human Research Ethics Chris Nelson, Director
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationGenesis Health System. Institutional Review Board. Standard Operating Procedures
Genesis Health System Institutional Review Board Table of Contents 1. INSTITUTIONAL AUTHORITY... 6 2. PURPOSE... 6 3. THE SCOPE & AUTHORITY OF THE IRB... 7 Scope...7 Authority of the GHS-IRB...7 Authority
More informationRecord or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;
TEXAS HEALTH RESOUCES Table 17-III. Record Retention Schedule Human Subject Research Records and Documents Approved by THR System Performance Council (SPC): 19 January 2010 Effective Date: October 14,
More informationThe Alfred Streamlining Ethical Review Guide. Overview Page 1. The Review Schemes - A description the two different schemes Page 2
The Alfred Streamlining Ethical Review Guide This Guide contains: Overview Page 1 The Review Schemes - A description the two different schemes Page 2 What is meant by Reviewing or Accepting? Page 2 Where
More informationGraduate Diploma In Mental Health (GDMH) Intake
Graduate Diploma In Mental Health (GDMH) Intake 2017-2018 Please tick the appropriate boxes accordingly. * Delete where applicable APPLICATION FORM (A) PERSONAL PARTICULARS Name (as in NRIC/Passport):
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationProcedures and Conditions of Building Consent Authority Accreditation
Procedures and Conditions of Building Consent Authority Accreditation Procedures and conditions of Building Consent Authority accreditation Fourth edition October 2015 general criteria for accreditation
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationNHG ROAM. ROAM Introductory Session. Research Online Administration & Management.
NHG ROAM Research Online Administration & Management ROAM Introductory Session www.research.nhg.com.sg Copyright 2016 National Healthcare Group. All Rights Reserved. Slide Deck version July 2016 Training
More informationNABH Accreditation Standards for Clinical Trials and application form. Indian Society for Clinical Research
Indian Society for Clinical Research Recommendations/Suggestions on NABH Accreditation Standards for Clinical Trials (Ethics Committee, Investigator and Clinical Trial Site) and application form Date:
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More information10 STEPS TO IRB APPROVAL
10 STEPS TO IRB APPROVAL STEP 1: OBTAIN CITI TRAINING CERTIFICATE ALL STUDY PERSONNEL MUST TAKE AN ONLINE HUMAN SUBJECTS TRAINING EDUCATION PROGRAM. THE CERTIFICATES OF COMPLETION ARE NEEDED FOR ALL STUDY
More informationRESEARCH GOVERNANCE GUIDELINES
RESEARCH GOVERNANCE GUIDELINES STUDY STEERING COMMITTEE (SSC) or TRIAL STEERING COMMITTEE (TSC) This document is designed to provide information and guidance relating to Steering Committees and Data Monitoring
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationRoles & Responsibilities of Investigator & IRB
Roles & Responsibilities of Investigator & IRB Jaranit Kaewkungwal Mahidol University Regulatory & Guidelines Regulatory & Guidelines GCP & Computer / Database Management Systems International Conference
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationIDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES
IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October
More informationQUALITY ASSURANCE PROGRAM
QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationIRB Process for SURF April 21, 2015
IRB Process for SURF April 21, 2015 UNC-CH IRBs Biomedical (A,B,C,D): Expertise is focused on biomedical research (clinical trials, pharmacological research, etc) Oncology = B and D Dentistry = B and D
More informationOffice of Human Research Office of Human Research Policy and Procedure Manual. Version: 4/4/18
Version: 4/4/18 Signatures on File for the Approval of Revisions to the Policy and Procedures Table of Contents 100 General Administration (GA)... 5 Policy GA 101: The Authority and Purpose of the Institutional
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationInstructions for Submitting your CE/Thesis/Dissertation Proposal
Instructions for Submitting your CE/Thesis/Dissertation Proposal All student CE, Thesis, and Dissertation proposals must be submitted to the UTSPH Office of Academic Affairs and Student Service for review
More informationVertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal Our Investigator Initiated Study grants support independent, investigator-initiated research designed to advance scientific knowledge of
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationCayuse IRB for Researchers
Cayuse IRB for Researchers 2 Table of Content What is CayuseIRB.. 3 Submission Workflow Chart. 5 Logging In.. 6 Dashboard. 8 Creating an Initial Review Request 10 Completing Forms.13 Determinations.. 29
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals Overall Agenda for Orientation Module 1:
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationRegistration prescribed information handbook
Registration prescribed information handbook Guidance for registered providers submitting prescribed information as part of a registration pack or a registration notification form. October 2016 Page 2
More informationUniversity Communications & Marketing Policies and Procedures
University Communications & Marketing Policies and Procedures Policy # Origination Date Responsible Office Status Approval Date 09-02-A-01 Feb. 2009 Communications & Marketing FINAL Oct. 5, 2009 Policy
More informationTOPIC: CONTRACTS STATE OF MISSISSIPPI DEPARTMENT OF EDUCATION SECTION 17.0 PAGE 1 OF 38 EFFECTIVE DATE: MAY 1, 2017 REVISION #4: MARCH 1, 2017
SECTION 17.0 PAGE 1 OF 38 CONTRACT PROCUREMENT POLICY The Mississippi Department of Education (Department) Contract Procurement Policy set forth herein applies to the procurement, management, and control
More informationM. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December
More information1 Abstract Calendar. 2 Submission Conditions. 3 Abstract Options. 4 Detailed Guidelines. 5 Abstract Corrections
ABSTRACT SUBMISSION 1 Abstract Calendar 2 Submission Conditions 3 Abstract Options 4 Detailed Guidelines 5 Abstract Corrections 6 Review 7 Registration of the Abstract Presenter 8 Presentation (E-posters)
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationGuidelines for Review of Research Involving Human Subjects
Institutional Review Board Assumption College Guidelines for Review of Research Involving Human Subjects Table of Contents: Page General Guidelines........ 1 Scope and Purpose of IRB Review...... 1 Basis
More informationNCI and VA Interagency Group to Accelerate Trials Enrollment (NAVIGATE) Request for Applications (RFA)
NCI and VA Interagency Group to Accelerate Trials Enrollment (NAVIGATE) Request for Applications (RFA) Release Date: November 15, 2017 SUBMISSION: DUE ON: SUBMIT TO: LETTER OF INTENT (as PDF file) 5 pm
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationRESEARCH SUBJECTS PROTECTION DIVISION
NAVAL MEDICAL CENTER PORTSMOUTH RESEARCH SUBJECTS PROTECTION DIVISION Guidebook for Extramural IRB Submissions Kersten Wheeler, MS Elizabeth Dayag, CIP, CCRP Melvina Queen, CIP, CCRP Research Subjects
More informationSARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY TITLE: Satellite Site Management Plan Job Title of Reviewer: POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY TYPE: Elizabeth Carr, R.N.,
More informationUniversity of California, San Diego Human Research Protections Program Institutional Review Board Standard Operating Policies and Procedures
University of California, San Diego Human Research Protections Program Institutional Review Board Standard Operating Policies and Procedures Version date: 5/28/2004 Table of Contents Section One: General
More informationGood Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording,
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationSAN DIEGO POLICE DEPARTMENT PROCEDURE
SAN DIEGO POLICE DEPARTMENT PROCEDURE DATE: March 25, 2016 NUMBER: SUBJECT: RELATED POLICY: ORIGINATING DIVISION: 1.40 ADMINISTRATION GRANT PROCEDURES N/A ADMINISTRATIVE SERVICES PROCEDURE: PROCEDURAL
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationSingapore Cancer Society
Singapore Cancer Society Research Portal Training Manual Submitting Research Application 1 The Singapore Cancer Society (SCS) Cancer Research Grant aims at delivering holistic patient care and hence it
More informationAPEC Preliminary Workshop: Review of Drug Development in Clinical Trials
APEC Preliminary Workshop: Review of Drug Development in Clinical Trials Session 9 B Clinical Trial Assessment Patient Protection Informed Consent Susan D Amico Vice President and Global Head Clinical
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More informationSection VII Provider Dispute/Appeal Procedures; Member Complaints, Grievances, and Fair Hearings
Section VII Provider Dispute/Appeal Procedures; Member Complaints, Grievances, and Fair Hearings Provider Dispute/Appeal Procedures; Member Complaints, Grievances and Fair Hearings 138 Provider Dispute/Appeal
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL REPORTING ADVERSE DRUG REACTIONS IN SOUTH AFRICA IMPORTANT NOTE This guideline applies only to the reporting of SAEs during clinical trials. An update of the guideline for this
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More information